Home ••• Newswires by Industry • Countries • U.S. States • World Media Directory

Pharmaceutical Industry News ••• Topics • Countries • U.S. States

Revlimid News Monitoring

Get by Email • RSS

Published on 14:31 GMT

Dr. Reddy’s Q1 net plunges 69% to ₹435.6 cr on lower revenue

Hyderabad-based generic drugmaker Dr. Reddy’s Laboratories’ consolidated net profit slumped 69% year-on-year (YoY) to ₹.435.6 crore in the June quarter amid lower sales of cancer drug lenalidomide and nearly ₹240 crore provision necessitated by recent …

Source: The Hindu - Center-left
Published on 11:41 GMT

India’s Dr Reddy’s posts quarterly profit slump on semaglutide inventory costs

HYDERABAD, July 22 (Reuters) – Indian drugmaker Dr Reddy’s reported a smaller-than-expected quarterly profit on Wednesday, weighed by inventory and related costs associated with disruptions to semaglutide supply, the company said. Consolidated net profit …

Source: WHBL - Wisconsin - Pending
Published on 12:55 GMT

Bank of America Says the Fed Should Raise Rates Now: 4 Dividend Inflation-Resistant Stocks

Everybody across the stock and bond markets breathed a huge sigh of relief when the consumer and producer price index numbers for June were released. The reality is that those great prints were largely due to plummeting gasoline prices, as the U.S. and …

Source: 24/7 Wall St. - Neutral
Published on Jul 20, 2026

<![CDATA[Study Redefines Functional High-Risk Multiple Myeloma in Modern-Therapy Era]]>

A relapse within 36 months of upfront quadruplet therapy and autologous stem cell transplantation (ASCT), rather than the historical 18-month benchmark, may best identify patients with functional high-risk multiple myeloma, according to a multicenter …

Source: Cancer Network - Pending
Published on Jul 14, 2026

<![CDATA[Repurposed Cancer Drug Lenalidomide Shows Feasibility and Safety in Phase 2 Study of MCI Due to Alzheimer ...

A phase 2 proof-of-mechanism trial evaluating the anti-cancer drug lenalidomide (Revlimid; BMS) as an immunomodulatory therapy for mild cognitive impairment (MCI) due to Alzheimer disease (AD) demonstrated feasibility and a manageable safety profile over …

Source: NeurologyLive - Neutral
Published on Jul 15, 2026

<![CDATA[Dr Cerchione on the FDA Approval of Subcutaneous Isatuximab in Myeloma]]>

The idea of sparing time in [without an] infusion is not only an addition for the patient, but [it] is a way to optimize the time in the hospital. Claudio Cerchione, MD, PhD, an adjunct professor in the Department of Pharmacy and Biotechnology at the …

Source: OncLive - Pending
Published on Jul 19, 2026

<![CDATA[Five Under 5: Top Oncology Videos for the Week of 7/12]]>

Welcome to The Five Under 5, your go-to roundup of the top 5 videos of the week. These short videos are designed for busy oncologists to view on the go, and feature expert insights on breaking news, regulatory updates, practice-changing data shared at …

Source: OncLive - Pending
Published on Jul 17, 2026

<![CDATA[OS Does Not Improve With Continuous Vs Fixed Lenalidomide Dosing in NDMM]]>

Indefinite-duration or continuous lenalidomide (Revlimid) maintenance did not significantly improve overall survival (OS) compared with a fixed 2-year duration in patients with standard-risk newly diagnosed multiple myeloma (NDMM) who were not undergoing …

Source: Cancer Network - Pending
Published on Jul 13, 2026

<![CDATA[FDA Accepts NDA for Mezigdomide Plus Kd in R/R Myeloma]]>

The FDA has accepted a new drug application (NDA) seeking the approval of mezigdomide (CC-92480) in combination with carfilzomib (Kyprolis) and dexamethasone (MeziKd) for the treatment of patients with relapsed or refractory multiple myeloma.1 The …

Source: OncLive - Pending
Published on Jul 20, 2026

<![CDATA[META 10-19 Elicits High Complete Response Rate at Ultra-Low Doses in High-Risk R/R DLBCL]]>

META 10-19, an IL-10–expressing anti-CD19 CAR T-cell therapy, elicited an objective response rate (ORR) of 100% in patients with high-risk relapsed/refractory diffuse large B-cell lymphoma (DLBCL) treated at ultra-low doses, according to data from a …

Source: OncLive - Pending
Published on Jul 10, 2026

<![CDATA[FDA Approves Subcutaneous Isatuximab in Multiple Myeloma]]>

The FDA has approved a subcutaneous formulation of isatuximab-irfc (Sarclisa Escena) in combination with standard-of-care regimens for patients with multiple myeloma across all currently approved indications for the agent’s intravenous formulation, …

Source: Cancer Network - Pending
Published on Jul 10, 2026

<![CDATA[FDA Approves Subcutaneous Isatuximab Delivered Via On-Body Delivery System for Multiple Myeloma]]>

The FDA has approved isatuximab-irfc (Sarclisa Escena) for subcutaneous injection for multiple myeloma indications. Subcutaneous isatuximab can be administered as a subcutaneous injection with the CirCLIQ on-body delivery system (OBDS) or with a syringe …

Source: OncLive - Pending
Published on Jul 7, 2026

<![CDATA[How Are CELMoDs Reshaping Treatment in Multiple Myeloma?]]>

In a Frontline Forum post-program interview, CancerNetwork spoke with Paul G. Richardson, MD, and Muhamed Baljevic, MD, FACP, about cereblon E3 ligase modulatory drugs (CELMoDs) in the treatment of multiple myeloma. The discussion covered the mechanistic …

Source: Cancer Network - Pending
Published on Jul 10, 2026

<![CDATA[FDA Approves Subcutaneous Isatuximab-irfc for Multiple Myeloma]]>

The US Food and Drug Administration (FDA) has announced the approval of isatuximab-irfc (Sarclisa Escena; Sanofi-Aventis U.S. LLC) for subcutaneous (SC) injection across several multiple myeloma (MM) indications. This approval provides oncology nurses and …

Source: Oncology Nursing News - Pending
Published on Jul 13, 2026

Agenus surges on study pivot; Apnimed lines up an IPO

Today, a brief rundown of news involving Agenus and the University of Oxford, as well as updates from Apnimed, Bristol Myers Squibb and Pfizer that you may have missed. Agenus has raised $340 million in private funding as part of a plan to change its …

Source: BioPharma Dive - Pending
Published on Jul 4, 2026

Woman says cancer drugs costing Rs 85,000 in US sell for Rs 35 in India: ‘Being robbed’

A social media reel is drawing widespread attention after a content creator compared the cost of a life-saving blood cancer medicine in India and the United States, reigniting conversations about the stark difference in healthcare and drug pricing between …

Source: The Indian Express - Center-left
Published on Jul 15, 2026

<![CDATA[Subcutaneous Isatuximab Approval Expands Options in Multiple Myeloma]]>

On July 9, 2026, the FDA approved subcutaneous isatuximab-irfc (Sarclisa Escena), administered via an on-body injector or manual subcutaneous injection, across all previously approved isatuximab indications in multiple myeloma.The agent was approved in …

Source: Cancer Network - Pending
Published on Jul 4, 2026

‘We are being robbed’: US woman stunned after finding Rs 85,000 cancer pill costs just Rs 35 in India

US woman stunned after finding Rs 85,000 cancer pill costs just Rs 35 in India | Image: Instagram New Delhi: An American woman living in India has gone viral after comparing the cost of a cancer medicine in India and the United States, calling the …

Source: News9 Live - Indeterminate
Published on Jul 3, 2026

Woman shocked by India-US price gap for life-saving cancer medicine, shares video

An American woman compared the cost of a life-saving cancer medicine in the US and India, saying the massive price difference left her stunned. The video was shared on Instagram by the account Spicy Gori, where the American woman spoke about the …

Source: India Today - Neutral

05 days 13:01:53

Featured Releases

Got News to Share? · Submit · See All

Published on July 22, 2026 - 11:05 GMT

Royalty Pharma acquires royalty interest in AstraZeneca’s cliramitug for up to $425 million from Neurimmune

NEW YORK, July 22, 2026 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it has acquired a portion of Neurimmune’s royalty interest in AstraZeneca’s cliramitug for up to $425 million, including $125 million upfront. Cliramitug is …

Distribution channels: Banking, Finance & Investment Industry, Companies ...
Published on July 22, 2026 - 11:00 GMT

OKYO Pharma Announces Purchase of Shares by Chief Medical Officer

LONDON and NEW YORK, July 22, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain (NCP) and anterior segment eye diseases …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on July 22, 2026 - 14:00 GMT

OKYO Pharma Announces Purchase of Shares by Chief Development Officer and Director

LONDON and NEW YORK, July 22, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain (NCP) and anterior segment eye diseases …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on July 22, 2026 - 12:05 GMT

Bluesight and Pfizer Partner to Provide Source-Tagged RFID Medications to Hospital Pharmacies

ALEXANDRIA, Va., July 22, 2026 (GLOBE NEWSWIRE) -- Pfizer’s SmartDose medications arrive pre-tagged and pre-associated for use with KitCheck, reducing manual tagging labor as part of RFID inventory management workflows Bluesight, the leader in hospital …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on July 22, 2026 - 12:00 GMT

LB Pharmaceuticals Announces Accelerated Timing of Topline Results from the Phase 3 NOVA-2 Trial of LB-102 in ...

NEW YORK, July 22, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a neuromedicines company dedicated to developing and commercializing high-impact therapies that address the multiple dimensions of …

Distribution channels: Technology ...
Published on July 22, 2026 - 13:22 GMT

REGENERNON PHARMACEUTICALS, INC. INVESTORS WITH LOSSES HAVE UNTIL SEPTEMBER 14, 2026 TO JOIN SECURITIES CLASS ACTION – ...

NEW YORK, July 22, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Regeneron Pharmaceuticals, Inc. (“Regeneron” or the “Company”) (NASDAQ: REGN) of the September 14, 2026 deadline involving a …

Distribution channels: Law ...
Published on July 22, 2026 - 12:39 GMT

New Analysis of Over 50 Studies Showed that All the Non-Prescription CBD Products Researched Fell Short of Therapeutic ...

Review Article Now Published in the British Journal of Clinical Pharmacology Finds Widely Sold Non-Prescription CBD Products at Doses Administered Failed to Provide Adequate Exposure for Positive Biological Effect Underscores the Need for Optimized CBD …

Distribution channels: Banking, Finance & Investment Industry, Science ...
Published on July 21, 2026 - 23:11 GMT

Bionpharma Invests in Xavion Lifesciences to Expand Global R&D Platform

PRINCETON, NJ, UNITED STATES, July 21, 2026 /⁨EINPresswire.com⁩/ -- PRINCETON, N.J., July 21, 2026 — Bionpharma Inc., a U.S.-based pharmaceutical company specializing in the development and commercialization of high-quality generic and over-the- …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Got news to share? Submit it now.

Load more pharmaceuticals news or search news using your own keywords. There are 928,572,678 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Pharmaceutical Industry News by Country

Pharmaceutical Industry News by U.S. State

Pharmaceutical Industry News Topics

Online News Publications

World News Report

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter

Create RSS Feed

NewsPlugin for WordPress

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire

Events

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 07/12/2026

World Media Directory

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All

Published on July 22, 2026 - 14:13 GMT

JOIN Enterprise Expands Global Reach With Fiberglass Casting Tape and Splints

Korean orthopedic device maker supplies synthetic cast and fiberglass splint products to hospitals in 50+ countries, replacing traditional plaster casts. NY, UNITED STATES, July 22, 2026 /⁨EINPresswire.com⁩/ -- JOIN Enterprise Co., Ltd., a South …

Distribution channels: Conferences & Trade Fairs, Consumer Goods ...
Published on July 22, 2026 - 14:00 GMT

Pro-Lab Diagnostics USA Launch Pro-AMP™ for Physician Office Lab Molecular Testing

Pro-AMP™ helps qualified physician office laboratories deploy rapid, patient-specific infectious disease testing through configurable isothermal workflows. GEORGETOWN, TX, UNITED STATES, July 22, 2026 /⁨EINPresswire.com⁩/ -- Pro-AMP™ is designed to help …

Distribution channels: Conferences & Trade Fairs, Food & Beverage Industry ...
Published on July 22, 2026 - 14:00 GMT

Harley Gordon Launches Insurance Education Advisors to Modernize Professional Insurance Education for the AI Era

Creator of the CLTC a nationally recognized long-term care designation launches a next-generation platform for online learning, credentials and digital trust. BOSTON, MA, UNITED STATES, July 22, 2026 /⁨EINPresswire.com⁩/ -- Harley Gordon, creator …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
Published on July 22, 2026 - 14:00 GMT

NeuraSignal’s Robotic TCD Powers New PFO Workflow at Royal Columbian Hospital

NeuraSignal showcases Royal Columbian Hospital’s use of the robotic NG2 system to improve PFO detection and stroke prevention with automated cerebral screening. LOS ANGELES, CA, UNITED STATES, July 22, 2026 /⁨EINPresswire.com⁩/ -- NeuraSignal Inc …

Distribution channels: Culture, Society & Lifestyle, Emergency Services ...
Published on July 22, 2026 - 13:56 GMT

Ultimate Mattress Protection: LivDry Introduces Disposable Bed Pads for Layered Overnight Incontinence Protection

New disposable underpads expand LivDry’s premium product line, helping adults and caregivers add another layer of protection for overnight bladder leakage WILSON, CT, UNITED STATES, July 22, 2026 /⁨EINPresswire.com⁩/ -- Nighttime bladder leakage …

Distribution channels: Consumer Goods, Healthcare & Pharmaceuticals Industry ...
Published on July 22, 2026 - 13:54 GMT

NHO Revive Announces Expanded Access Protocol for Daraxonrasib

NHO Revive will offer pre-approval access to Daraxonrasib for eligible stage 4 pancreatic cancer patients through an Expanded Access Protocol. NEBRASKA, NE, UNITED STATES, July 22, 2026 /⁨EINPresswire.com⁩/ -- NHO Revive is pleased to announce …

Distribution channels: Education, Healthcare & Pharmaceuticals Industry ...
Published on July 22, 2026 - 13:53 GMT

NHO Revive Becomes Nebraska's Only Site for Groundbreaking Prostate Cancer Clinical Trial

NHO Revive becomes Nebraska's only site for a Johnson & Johnson Phase 3 trial testing a novel immune therapy for prostate cancer. NEBRASKA'S , NE, UNITED STATES, July 22, 2026 /⁨EINPresswire.com⁩/ -- The study, sponsored by Johnson …

Distribution channels: Education, Healthcare & Pharmaceuticals Industry ...
Published on July 22, 2026 - 13:48 GMT

Nutraland USA Launches Vegadelight® CleanShield™ for Clean-Label Vitamin D3 Stability in Multi-Nutrient Formulations

Proprietary plant-based CleanShield™ technology delivers proven stability in high-stress, multi-nutrient matrix without synthetic additives or modified starches IRVINE, CA, UNITED STATES, July 22, 2026 /⁨EINPresswire.com⁩/ -- Nutraland USA, Inc …

Distribution channels: Beauty & Hair Care, Business & Economy ...
Published on July 22, 2026 - 13:32 GMT

Probate Services, Inc. Highlights Professional Probate and Fiduciary Support for California Families

Professional probate administration and fiduciary services supporting California families, executors, trustees, and attorneys. CAMARILLO, CA, UNITED STATES, July 22, 2026 /⁨EINPresswire.com⁩/ -- Probate Services, Inc. Highlights Professional …

Distribution channels: Business & Economy, Companies ...
Published on July 22, 2026 - 13:30 GMT

The Ex-IBM Chief AI Officer Who Left in 2022 Says the Industry's AI Safety Model Is Structurally Broken.

His Lab Just Published the Alternative. Releasing the "Unfireable Safety Kernel" a shipped, verified enforcement layer that sits outside the AI agent it governs RIDEGFIELD, CT, UNITED STATES, July 22, 2026 /⁨EINPresswire.com⁩/ -- ARYA …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
Published on July 22, 2026 - 13:30 GMT

Benefit Advisors Network Appoints Susan Rider as Human Capital Management Director

Seasoned Human Resources Executive Brings Deep Expertise in Workforce Strategy, Compliance and Organizational Effectiveness CLEVELAND, OH, UNITED STATES, July 22, 2026 /⁨EINPresswire.com⁩/ -- Benefit Advisors Network (BAN), an international …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
Published on July 22, 2026 - 13:00 GMT

Younger British men are embracing beauty tourism, KAYAK research reveals

Beauty treatments are increasingly becoming part of the holiday experience, with younger British men leading the trend, according to KAYAK research. LONDON, UNITED KINGDOM, July 22, 2026 /⁨EINPresswire.com⁩/ -- Beauty tourism is getting a male …

Distribution channels: Beauty & Hair Care, Culture, Society & Lifestyle ...
Published on July 22, 2026 - 13:00 GMT

Announcing 2026 Tampa Bay Titan 100

TAMPA BAY, FL, UNITED STATES, July 22, 2026 /⁨EINPresswire.com⁩/ -- Titan CEO and headline Enavate are pleased to announce the 2026 Tampa Bay Titan 100. The Titan 100 program recognizes Tampa Bay’s Top 100 CEOs & C-level executives. They are …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
Published on July 22, 2026 - 13:00 GMT

Aquablue Expands Midwest Presence with Senior Appointment

Marlo Schrieber Sr Director of Business Development, has 15+ years of experience helping clients navigate infrastructure, connectivity, and digital complexities MORRISTOWN, NJ, UNITED STATES, July 22, 2026 /⁨EINPresswire.com⁩/ -- Aquablue, the …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
Published on July 22, 2026 - 13:00 GMT

Renowned Aerospace and Infrastructure Architect Danne Stayskal Joins Hurone AI as CTO

Former NASA Systems Architect, Oracle Cloud Technical Lead, & Stripe Software Systems Lead Brings Global Scale Expertise to Cancer Care AI Startup SEATTLE, WA, UNITED STATES, July 22, 2026 /⁨EINPresswire.com⁩/ -- Hurone AI, an artificial …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on July 22, 2026 - 13:00 GMT

Elgin Cosmetic Dentist Debunks Common Dental Implant Myths

Dr. Dean Lodding dispels misconceptions about dental implants, including who qualifies for the procedure and how natural the results can look. ELGIN, IL, UNITED STATES, July 22, 2026 /⁨EINPresswire.com⁩/ -- Misconceptions about tooth replacement …

Distribution channels: Beauty & Hair Care, Companies ...
Published on July 22, 2026 - 13:00 GMT

Acrosian Launches as AI-Era Biometric CRO, Built by a Team From One of the Industry's Largest Independent Biometric CROs

Built for AI, not retrofitted for AI. PRINCETON, NJ, UNITED STATES, July 22, 2026 /⁨EINPresswire.com⁩/ -- Acrosian LLC today announced its launch as a next-generation biometrics CRO purpose-built for the AI era. Founded by Benjamin Jackson, …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
Published on July 22, 2026 - 13:00 GMT

Medmio's Medical Coding AI Hits 98.1% Accuracy — and Shows Its Work

Medmio's CodeSight AI medical coding engine reached 98.1% accuracy on charts it had never seen — published with the complete evidence base behind every number. SAN DIEGO, CA, UNITED STATES, July 22, 2026 /⁨EINPresswire.com⁩/ -- Medmio has …

Distribution channels: Healthcare & Pharmaceuticals Industry, IT Industry ...
Published on July 22, 2026 - 12:49 GMT

Urteste Publishes First Peer-Reviewed Paper on Panuri Technology

Urteste announces the publication of the first peer-reviewed scientific article describing the analytical validation of its Panuri test for pancreatic cancer. URTESTE S.A. (WSE:URT) LOS ANGELES, CA, UNITED STATES, July 22, 2026 /⁨EINPresswire.com⁩…

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on July 22, 2026 - 12:47 GMT

Memory Stones Expands Multicultural Memorial Services Across All 50 States and a Full Spanish-Language Platform

The national headstone retailer serves Hispanic, Jewish, Asian, Orthodox and other designs, multilingual support, and in-stock granite shipped free nationwide LOS ANGELES, CA, UNITED STATES, July 22, 2026 /⁨EINPresswire.com⁩/ -- Memory Stones, the …

Distribution channels: Building & Construction Industry, Companies ...